antiviral therapy

Biotech

Virios fails in fibromyalgia but claims efficacy in omicron era

While the prospect failed to improve pain more than placebo did, Virios is making the case that it was effective after the emergence of omicron.
Nick Paul Taylor Sep 19, 2022 9:00am

Pfizer, in a rare COVID-19 setback, dumps Paxlovid's IV sibling 

Feb 8, 2022 8:20am

Novartis splashes cash on COVID-19 antiviral, plans FDA filing 

Jan 10, 2022 4:48am

Pfizer's COVID-19 antiviral is expected to work against omicron

Dec 14, 2021 10:30am

Pfizer's oral COVID antiviral cuts hospitalization, death by 89%

Nov 5, 2021 7:41am

Antios raises a further $75M to fuel pursuit of hepatitis B cure

Nov 3, 2021 9:15am